These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 9024376)

  • 41. Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany.
    Meier P; Schuff-Werner P; Steiner M
    Clin Lab; 2005; 51(9-10):539-43. PubMed ID: 16285477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Porphyria cutanea tarda and HLA-linked hemochromatosis. Evidence against a systematic association.
    Beaumont C; Fauchet R; Phung LN; De Verneuil H; Gueguen M; Nordmann Y
    Gastroenterology; 1987 Jun; 92(6):1833-8. PubMed ID: 3569756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
    Frank J; Poblete-Gutiérrez P; Weiskirchen R; Gressner O; Merk HF; Lammert F
    Physiol Res; 2006; 55 Suppl 2():S75-83. PubMed ID: 17298224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis.
    Barton JC; Shih WW; Sawada-Hirai R; Acton RT; Harmon L; Rivers C; Rothenberg BE
    Blood Cells Mol Dis; 1997; 23(1):135-45; discussion 145a-b. PubMed ID: 9215758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of functional mutations in the ferroportin-encoding SLC40A1 gene in porphyria cutanea tarda: a series of 37 cases from southern France.
    Du Thanh A; Martinez P; Cunat S; Bessis D; Guillot B; Dereure O
    Acta Derm Venereol; 2011 Jun; 91(4):467. PubMed ID: 21607294
    [No Abstract]   [Full Text] [Related]  

  • 46. [59-year-old patient with cutaneous lesions and increased iron metabolism parameters].
    Mangold E; Diepolder H; Lohse P; Pape GR; Ritter MM
    Internist (Berl); 2000 Oct; 41(10):1103-7. PubMed ID: 11084896
    [No Abstract]   [Full Text] [Related]  

  • 47. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
    Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haemochromatosis: automated detection of the two point mutations in the HFE gene: Cys282Tyr and His63Asp.
    Klingler KR; Zech D; Wielckens K
    Clin Chem Lab Med; 2000 Dec; 38(12):1225-30. PubMed ID: 11205685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: a prospective study.
    Dereure O; Jumez N; Bessis D; Gallix B; Guillot B
    Acta Derm Venereol; 2008; 88(4):341-5. PubMed ID: 18709302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are His63Asp or Cys282Tyr HFE mutations associated with porphyria cutanea tarda? Data of patients from central and southern Italy.
    D'Amato M; Macrí A; Griso D; Biolcati G; Ameglio F
    J Invest Dermatol; 1998 Dec; 111(6):1241-2. PubMed ID: 9856853
    [No Abstract]   [Full Text] [Related]  

  • 51. Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population.
    Florkowski CM; George PM; Willis JA; Stott MK; Burt MJ; Upton JD; Nesbit J; Walmsley TA; Scott RS
    Diabetes Res Clin Pract; 1999 Mar; 43(3):199-203. PubMed ID: 10369430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
    Tannapfel A; Stölzel U; Köstler E; Melz S; Richter M; Keim V; Schuppan D; Wittekind C
    Virchows Arch; 2001 Jul; 439(1):1-5. PubMed ID: 11499833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HFE gene mutations in coronary atherothrombotic disease.
    Calado RT; Franco RF; Pazin-Filho A; Simões MV; Marin-Neto JA; Zago MA
    Braz J Med Biol Res; 2000 Mar; 33(3):301-6. PubMed ID: 10719381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating pro- and antioxidant factors in iron and porphyrin metabolism disorders.
    Rocchi E; Casalgrandi G; Masini A; Giovannini F; Ceccarelli D; Ferrali M; Marchini S; Ventura E
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):861-7. PubMed ID: 10669994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
    Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
    Bertoli LF; Barton JC
    Clin Breast Cancer; 2007 Aug; 7(9):716-8. PubMed ID: 17919354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
    Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
    Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?
    Martinelli AL; Franco RF; Villanova MG; Figueiredo JF; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Zago MA
    Acta Haematol; 2000; 102(3):152-6. PubMed ID: 10692680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.